VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani, +19

Cancer Science

Age-related alteration in the distribution of methylglyoxal and its metabolic enzymes in the mouse brain

Shin Koike, Chihiro Ando, Yosuke Usui, +4

Brain Research Bulletin

AgingLipid PeroxidationPhysiologyMouse BrainNeuroscience +6

CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in <i>Egfr</i> -Mutant Lung Cancer

Kazuya Nishii, Kadoaki Ohashi, Shuta Tomida, +19

Cancer Immunology Research

Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non‐small‐cell lung cancer

Ayako Morita, Eiki Ichihara, Koji Inoue, +17

International Journal of Cancer

Multiple Mucosa-associated Lymphoid Tissue Lymphoma of the Trachea

Daisuke Minami, Chihiro Ando, Ken Sato, +8

Internal Medicine

AsthmaPrimary Pulmonary CarcinomaMultiple NodulesLymphoid NeoplasiaAllergy +12

SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve <i>ALK-, ROS1-</i> , or <i>EGFR</i> -altered Non–small Cell Lung Cancer

Hirohisa Kano, Eiki Ichihara, Hiromi Watanabe, +12

Molecular Cancer Therapeutics

Efficacy of afatinib treatment for lung adenocarcinoma harboring exon 18 delE709_T710insD mutation

Yoshitaka Iwamoto, Eiki Ichihara, Naofumi Hara, +6

Japanese Journal of Clinical Oncology

Surgical OncologyLung AdenocarcinomaDele709_t710insd MutationPathologyAfatinib Treatment +14

Mechanical particle coating using ethylcellulose nanoparticle agglomerates for preparing controlled release fine particles; effect of coating temperature on coating performance

Keita Kondo, Chihiro Ando, Toshiyuki Niwa

International Journal of Pharmaceutics

Materials ScienceThermal Spray CoatingEngineeringMechanical EngineeringMechanical Particle +2

First and repeat rebiopsy for detecting EGFR T790M mutation in non-small-cell lung cancer: CS-Lung-003 prospective observational registry study

Kenichiro Kudo, Kazuya Nishii, Go Makimoto, +14

Journal of Cancer Research and Clinical Oncology

OncologyNon-small-cell Lung CancerMedicinePathologyCancer Genomics +6

CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer

Naofumi Hara, Eiki Ichihara, Hirohisa Kano, +17

Translational Lung Cancer Research